ENTASIS THERAPEUTICS HLDGS I's ticker is ETTX and the CUSIP is 293614103. A total of 23 filers reported holding ENTASIS THERAPEUTICS HLDGS I in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,159,000 | -71.0% | 568,004 | -57.9% | 0.00% | -76.5% |
| Q2 2020 | $3,997,000 | -6.7% | 1,350,490 | -16.8% | 0.02% | -45.2% |
| Q1 2020 | $4,286,000 | -46.9% | 1,623,405 | 0.0% | 0.03% | -40.4% |
| Q4 2019 | $8,068,000 | -16.6% | 1,623,405 | 0.0% | 0.05% | -7.1% |
| Q3 2019 | $9,675,000 | -7.6% | 1,623,405 | 0.0% | 0.06% | +1.8% |
| Q2 2019 | $10,471,000 | -4.6% | 1,623,405 | 0.0% | 0.06% | +3.8% |
| Q1 2019 | $10,974,000 | +66.1% | 1,623,405 | 0.0% | 0.05% | +43.2% |
| Q4 2018 | $6,607,000 | – | 1,623,405 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|